MYC could either directly or cooperate with other oncogenes to regulate the expression of PD-L1 to inhibit the function of immune cells or remodel the tumor microenvironment by recruiting macrophages that promote angiogenesis and reduce T cell infiltration (Casey et al., 2018). The gene discussed is CD274; the disease is neoplasm.